Fairness opinions › Bankers
Cantor Fitzgerald: healthcare fairness opinions
1 opinions in healthcare transactions, 2019-2019 — 1 to the target board. Each links to the filing and the full summary of analyses.
Opinions
1
2019-2019
Typical DCF discount rate
10.5%–12.5%
median of low / high · n=1
Terminal method
exit multiple 1
Median disclosed fee
—
n=0
Deals
| Announced | Target | Acquirer | Segment | EV | EV/EBITDA | EV/Rev | DCF rate |
|---|---|---|---|---|---|---|---|
| 2019-03-13 | Osiris Therapeutics | Smith & Nephew | Medical Devices and Supplies | $660M | 28.8x | 4.19x | 10.5%–12.5% |
Segments: Medical Devices and Supplies (1)
3,000+ healthcare deal-level valuation multiples
The Valuation database includes financial details for more than 3,000 healthcare M&A transactions, private and public, with deal-level multiples, categorized by segment, type, and year.